Show simple item record

Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer

dc.contributor.authorYılmaz, Mehmet
dc.contributor.authorKARAASLAN, Mustafa
dc.contributor.authorTonyali, Senol
dc.contributor.authorCEYLAN, Cavit
dc.date.accessioned2021-03-06T11:11:58Z
dc.date.available2021-03-06T11:11:58Z
dc.date.issued2018
dc.identifier.citationTonyali S., KARAASLAN M., Yılmaz M., CEYLAN C., "Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer", UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.17, ss.120-123, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_ede387c5-6384-446d-a823-a4e04100655b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/156183
dc.identifier.urihttps://doi.org/10.4274/uob.1001
dc.description.abstractObjective: To reveal the association of side effect profiles seen in patients receiving intravesical bacillus Calmette-Guerin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) treatment with patient age and possible changes over time due to the use of different BCG strains.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleEvaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer
dc.typeMakale
dc.relation.journalUROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
dc.contributor.departmentSağlık Bilimleri Üniversitesi , ,
dc.identifier.volume17
dc.identifier.issue4
dc.identifier.startpage120
dc.identifier.endpage123
dc.contributor.firstauthorID105556


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record